<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000530319">
  <TermName>AT7519M</TermName>
  <TermDefinition>
    <DefinitionText>A substance being studied in the treatment of some types of cancer. AT7519M blocks enzymes needed for cells to divide. It is a type of cyclin-dependent kinase inhibitor. Also called CDK inhibitor AT7519M.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <SpanishTermName>AT7519M</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Sustancia en estudio para el tratamiento de algunos tipos de cáncer. AT7519M bloquea unas enzimas necesarias para la división celular. Es un tipo de inhibidor de cinasas dependientes de ciclinas. También se llama inhibidor de CDK AT7519M.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2007-05-04</DateFirstPublished>
</GlossaryTerm>
